SeekingAlpha · Aug 6, 2026
Otsuka Holdings Co., Ltd. (OTSKY) Discusses 24-Month eGFR Results of Sibeprenlimab in IgA Nephropathy from Phase III VISIONARY Study - Slideshow
2026-08-06. The following slide deck was published by Otsuka Holdings Co., Ltd.

